K Number
K994320
Device Name
CHROMAGEN V2.0 HAPLOSCOPIC SYSTEM & COLOR VISION ENHANCEMENT SOFT CONTACT LENSES
Date Cleared
2000-10-20

(303 days)

Product Code
Regulation Number
886.5925
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses are indicated for daily wear to enhance color discrimination in patients with protan or deutan (red-green) color vision deficiencies. The lens may also be prescribed for the correction of refractive ametropia (myopia, hyperopia and astigmatism) in aphakic and not aphakic persons with non-diseased eyes. The lenses are disinfected using a hydrogen peroxide lens care system only and are available in a frequent replacement program.
Device Description
The ChromaGen v2.0 Color Discrimination Enhancement filters are designed specifically to improve discrimination between colors that are normally confused by people with protan or deutan (red-green) color vision deficiencies. The ChromaGen v20 Color Discrimination Enhancement Soft Contact Lenses are a range of soft contact lenses with precision tinted pupils of varying hue and saturation which, when used monocular and binocularly, have been shown to be of use in patients with defective color vision. Use of this product may enhance the discrimination of certain colors and may reduce the discrimination of certain colors. This device in not a cure for color vision deficiencies or colorblindness. The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are tinted with FDA "listed" color additives. The color additives are used in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect. As part of the manufacturing process, the lens containing the color additives are thoroughly washed to remove unbound reactive color additives. The manufacturing process alters and/or changes the specifications to the clear version of a contact lens by affixing a listed reactive on that portion of the anterior (front) surface of the lens that corresponds to the iris. The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are tinted to the eyecare professional instructions. The ChromaGen color additive effect is formed by reacting one or more of the reactive color additives listed in this paragraph with (poly hydroxyethy) methacrylate). The reactive color additives that may be used either alone or in combination are: reactive black 5, reactive blue 21, reactive blue 19, reactive blue 4, reactive blue 163, reactive red 11, reactive red 180, reactive yellow 15, reactive yellow 86, or reactive orange 78. The color additives used are not removed by lens handling or approved cleaning/disinfecting procedures. The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses tinting process does not alter the optical and/or performance characteristics of the finished tinted soft contact lens.
More Information

Not Found

Not Found

No
The device description focuses on the physical properties of tinted contact lenses and a haploscopic system, with no mention of AI or ML algorithms for image processing, data analysis, or personalized adjustments.

Yes
The device is indicated to "enhance color discrimination in patients with protan or deutan (red-green) color vision deficiencies," which addresses a medical condition, and can also be prescribed for "the correction of refractive ametropia." These are therapeutic uses.

No

The device is indicated for enhancing color discrimination and correcting refractive ametropia. Its primary function is to alter perception or correct vision, not to diagnose a medical condition.

No

The device description clearly states that the device is a soft contact lens with precision tinted pupils, which is a physical hardware component. The description details the materials and manufacturing process of the lens itself.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses are a medical device worn on the eye. Their function is to enhance color discrimination and correct refractive errors. They do not analyze biological samples to provide diagnostic information.
  • Intended Use: The intended use clearly states the purpose is to enhance color discrimination and correct vision, not to diagnose a condition.

Therefore, this device falls under the category of a medical device, specifically a contact lens, rather than an in vitro diagnostic.

N/A

Intended Use / Indications for Use

The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses are indicated for daily wear to enhance color discrimination in patients with protan or deutan (red-green) color vision deficiencies. The lens may also be prescribed for the correction of refractive ametropia (myopia, hyperopia and astigmatism) in aphakic and not aphakic persons with non-diseased eyes. The lenses are disinfected using a hydrogen peroxide lens care system only and are available in a frequent replacement program.

Product codes (comma separated list FDA assigned to the subject device)

LPL, NCZ

Device Description

The ChromaGen v2.0 Color Discrimination Enhancement filters are designed specifically to improve discrimination between colors that are normally confused by people with protan or deutan (red-green) color vision deficiencies

The ChromaGen v20 Color Discrimination Enhancement Soft Contact Lenses are a range of soft contact lenses with precision tinted pupils of varying hue and saturation which, when used monocular and binocularly, have been shown to be of use in patients with defective color vision. Use of this product may enhance the discrimination of certain colors and may reduce the discrimination of certain colors. This device in not a cure for color vision deficiencies or colorblindness.

The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are tinted with FDA "listed" color additives. The color additives are used in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect. As part of the manufacturing process, the lens containing the color additives are thoroughly washed to remove unbound reactive color additives. The manufacturing process alters and/or changes the specifications to the clear version of a contact lens by affixing a listed reactive on that portion of the anterior (front) surface of the lens that corresponds to the iris. The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are tinted to the eyecare professional instructions.

The ChromaGen color additive effect is formed by reacting one or more of the reactive color additives listed in this paragraph with (poly hydroxyethy) methacrylate). The reactive color additives that may be used either alone or in combination are: reactive black 5, reactive blue 21, reactive blue 19, reactive blue 4, reactive blue 163, reactive red 11, reactive red 180, reactive yellow 15, reactive yellow 86, or reactive orange 78. The color additives used are not removed by lens handling or approved cleaning/disinfecting procedures. The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses tinting process does not alter the optical and/or performance characteristics of the finished tinted soft contact lens.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 886.5925 Soft (hydrophilic) contact lens.

(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.

0

OCT 2 0 2000

510 (k): SUMMARY OF SAFETY AND EFFECTIVENESS

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

K994320 The assigned 510(k) number is:

Applicant information:

Date Prepared:October 1, 2000
Name:Cantor & Silver Limited
AddressMarket Place
Brackley Northants
England NN13 7DP
Contact Person:Mr. David Cantor
Managing Director/President
Phone Number:
Fax:011 44 1280 702002
011 44 1280 703003
USA Consultant:Martin Dalsing,
Med-Vice Consulting, Inc.
Consultant for Cantor & Silver, Inc.
623 Glacier Drive
Grand Junction, CO 81503
(970) 243-5490
Fax #: (970) 243-5501 E-mail: mdalsing@gj.net

Device Infor

Device Classification:Class II
Classification Number:LPL, NCZ
Trade Name:ChromaGen v2.0 Haploscopic System &
Color Discrimination Enhancement Soft Contact
Lens
Classification Name:Lens, Soft Contact, Daily Wear

1

SUMMARY BASIS for Substantial Equivalence ~

Substantially Equivalent Devices:

The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are substantially equivalent to the "X-Chrom" RED Tinted PMMA Contact Lens" and the Cantor & Silver "CANTOR & SILVER 5X Tinted", the predicate devices.

NOTE: The "X-Chrom" RED Tinted lens is classified as a pre-amendment device.

Device Descriptive Characteristics:

The ChromaGen v2.0 Color Discrimination Enhancement filters are designed specifically to improve discrimination between colors that are normally confused by people with protan or deutan (red-green) color vision deficiencies

The ChromaGen v20 Color Discrimination Enhancement Soft Contact Lenses are a range of soft contact lenses with precision tinted pupils of varying hue and saturation which, when used monocular and binocularly, have been shown to be of use in patients with defective color vision. Use of this product may enhance the discrimination of certain colors and may reduce the discrimination of certain colors. This device in not a cure for color vision deficiencies or colorblindness.

The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are tinted with FDA "listed" color additives. The color additives are used in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect. As part of the manufacturing process, the lens containing the color additives are thoroughly washed to remove unbound reactive color additives. The manufacturing process alters and/or changes the specifications to the clear version of a contact lens by affixing a listed reactive on that portion of the anterior (front) surface of the lens that corresponds to the iris. The ChromaGen v2.0 Color Discrimination Enhancement Soft Contact Lenses are tinted to the eyecare professional instructions.

The ChromaGen color additive effect is formed by reacting one or more of the reactive color additives listed in this paragraph with (poly hydroxyethy) methacrylate). The reactive color additives that may be used either alone or in combination are: reactive black 5, reactive blue 21, reactive blue 19, reactive blue 4, reactive blue 163, reactive red 11, reactive red 180, reactive yellow 15, reactive yellow 86, or reactive orange 78. The color additives used are not removed by lens handling or approved cleaning/disinfecting procedures. The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses tinting process does not alter the optical and/or performance characteristics of the finished tinted soft contact lens.

2

PRECAUTION FOR CHROMAGEN LENSES

Special precaution for ChromaGen practitioners regarding the possible alterations in spatial perception.

Patients using the darker shades of tint in their ChromaGen lenses may experience some or all of the following:

  • reduced low contrast acuity, -
  • reduced illumination at night, -
  • distortions in distance perception of moving objects or while driving, »
  • distortions of apparent velocity. -

Thus, wearing these darker lenses may make driving difficult, especially at night, or under foggy, misty, or other adverse conditions.

INDICATIONS FOR USE STATEMENT

The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses are indicated for daily wear to enhance color discrimination in patients with protan or deutan (red-green) color vision deficiencies. The lens may also be prescribed for the correction of refractive ametropia (myopia, hyperopia and astigmatism) in aphakic and not aphakic persons with non-diseased eyes. The lenses are disinfected using a hydrogen peroxide lens care system only and are available in a frequent replacement program.

3

SUBSTANTIAL EQUIVALENCE TABLE

The following table summarizes Cantor & Silver Limited claim of substantial equivalency in terms of safety and efficacy to the predicate devices previously mentioned.

| | Characteristic | ChromaGen V2.0 | X-CHROM LENS
(pre-amendment device) | Cantor & Silver
5X Prosthetic |
|-----|-----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1.) | INDICATION
for USE | The ChromaGen v2.0
Haploscopic System & Color
Discrimination Enhancement
Soft Contact Lenses are
indicated for daily wear to
enhance color discrimination in
patients with protan or deutan
(red-green) color vision
deficiencies. The lens may also
be prescribed for the correction
of refractive ametropia (myopia,
hyperopia and astigmatism) in
aphakic and not aphakic persons
with non-diseased eyes. The
lenses are disinfected using a
hydrogen peroxide lens care
system only and are available in
a frequent replacement program. | Correction of color-blindness particularly
red-green color blindness.
NOTE: Not regulated (pre-amendment
device) | The Cantor & Silver 5X
Prosthetic Tinted Soft Contact
Lenses are indicated for daily
wear to enhance or alter the
apparent eye color, including
ocular masking, either in sighted
or non-sighted eyes that require a
prosthetic contact lens for
cosmetic management of
conditions such as corneal, iris or
lens abnormalities. The lens
may also be prescribed for the
correction of refractive ametropia
(myopia, hyperopia and
astigmatism) in aphakic and not
aphakic persons or for occlusive
therapy for conditions such as
diplopia, amblyopia or extreme
photophobia. The lenses are
disinfected using a hydrogen
peroxide lens care system only
and are available in a frequent
replacement program. |
| 2.) | Production
Method | Lathe-Cut | Lathe-cut | Lathe-cut |
| 3.) | Contact Lens
Material | hydrophilic | PMMA | hydrophilic |
| 3.) | FDA Listed
Color Additives | The reactive colored additives
consist of reactive black 5,
reactive blue 4, reactive blue 19,
reactive 21, reactive blue 163,
reactive yellow 15, reactive
yellow 86, reactive orange 78,
reactive red 11 and reactive red
180. | Not Available | The reactive colored additives
consist of reactive black 5,
reactive blue 4, reactive blue 19,
reactive 21, reactive blue 163,
reactive yellow 15, reactive
yellow 86, reactive orange 78,
reactive red 11 and reactive red
180. |
| 4.) | Color Additive
Characteristics | The color additives used are not
removed by lens handling and
approved cleaning/disinfecting
procedures. The optical and
performance characteristics are
not altered by the lens coloring
process. | The color additives used are not
removed by lens handling and
approved cleaning/disinfecting
procedures. The optical and
performance characteristics are not
altered by the lens coloring process. | The color additives used are not
removed by lens handling and
approved cleaning/disinfecting
procedures. The optical and
performance characteristics are
not altered by the lens coloring
process. |
| 5.) | Use and
restrictions | The color additives listed above
may be used to color contact
lenses in amounts not to exceed
the minimum reasonably
required to accomplish the
intended prosthetic effect. | Not Available | The color additives listed above
may be used to color contact
lenses in amounts not to exceed
the minimum reasonably
required to accomplish the
intended prosthetic effect. |

4

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

OCT 2 0 2000

Mr. Martin Dalsing Consultant for Cantor & Silver Limited c/o Medvice Consulting, Inc. 623 Glacier Drive Grand Junction, CO 81503

Re: K994320 Trade Name: The ChromaGeny20 Haploscopic System & Color Discrimination Enhancement Soft Lenses Regulatory Class: II Product Code: 86 NCZ Dated: August 21, 2000 Received: August 24, 2000

Dear Mr. Dalsing:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

5

Page 2 – Mr. Martin Dalsing

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed noctication " THE I Dr I milling sification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-6413. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,
A. Ralph Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

6

INDICATIONS FOR USE STATEMENT

Device Name:

ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lens

INDICATIONS FOR USE:

The ChromaGen v2.0 Haploscopic System & Color Discrimination Enhancement Soft Contact Lenses are indicated for daily wear to enhance color discrimination in patients with protan or deutan (red-The lens may also be prescribed for the correction of refractive green) color vision deficiencies. green) color vision deliciences. - The tenism) in aphakic and not aphakic persons with non-diseased antenopia (nyopia, ifyoropa and mings.hudrogen peroxide lens care system only and are available in a frequent replacement program.

(PLEASE DO OT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Heve Hilmanto
(Division Sign-Off)
Division of Ophthalmic Devices
510(k) Number. K994370

Prescription Use
(Per 21 CFR 801.109)

or

Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________

(Optional Format 1-2-96)